Group 1 - CG Oncology, Inc. (CGON) closed at $26.42, with a 2.2% gain over the past four weeks, and has a mean price target of $68.14, indicating a potential upside of 157.9% [1] - The mean estimate consists of seven short-term price targets with a standard deviation of $9.87, where the lowest estimate of $55 suggests a 108.2% increase, and the highest estimate of $83 indicates a 214.2% surge [2] - Analysts show strong agreement on CGON's ability to report better earnings than previously predicted, which supports the view of potential upside [4][11] Group 2 - The Zacks Consensus Estimate for CGON's current year earnings has increased by 2% over the last 30 days, with one estimate moving higher and no negative revisions [12] - CGON holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside [13] - While price targets may not be reliable indicators of actual stock gains, the direction they imply appears to be a good guide for potential price movement [13]
Wall Street Analysts Believe CG Oncology, Inc. (CGON) Could Rally 157.91%: Here's is How to Trade